Virax Biolabs Group Ltd (VRAX)
1.94
+0.01
(+0.52%)
USD |
NASDAQ |
Sep 27, 16:00
1.94
0.00 (0.00%)
After-Hours: 20:00
Virax Biolabs Group Price: 1.94 for Sept. 27, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 27, 2024 | 1.93 | 2.01 | 1.89 | 1.94 | 246706.0 |
| Sep 26, 2024 | 1.95 | 2.04 | 1.88 | 1.93 | 366075.0 |
| Sep 25, 2024 | 1.89 | 2.04 | 1.84 | 1.99 | 320409.0 |
| Sep 24, 2024 | 2.25 | 2.25 | 1.93 | 1.93 | 963707.0 |
| Sep 23, 2024 | 2.44 | 2.51 | 2.22 | 2.23 | 426539.0 |
| Sep 20, 2024 | 2.50 | 2.56 | 2.43 | 2.44 | 554530.0 |
| Sep 19, 2024 | 2.69 | 2.69 | 2.46 | 2.53 | 860586.0 |
| Sep 18, 2024 | 2.85 | 2.93 | 2.68 | 2.69 | 322488.0 |
| Sep 17, 2024 | 2.72 | 3.02 | 2.53 | 2.87 | 1.278M |
| Sep 16, 2024 | 3.51 | 3.549 | 2.675 | 2.84 | 14.83M |
| Sep 13, 2024 | 2.57 | 2.66 | 2.40 | 2.59 | 486499.0 |
| Sep 12, 2024 | 2.90 | 2.95 | 2.620 | 2.63 | 1.117M |
| Sep 11, 2024 | 2.96 | 3.26 | 2.92 | 2.99 | 1.029M |
| Sep 10, 2024 | 3.13 | 3.18 | 2.84 | 3.00 | 856917.0 |
| Sep 09, 2024 | 3.50 | 3.50 | 3.17 | 3.19 | 819853.0 |
| Sep 06, 2024 | 3.96 | 4.261 | 3.51 | 3.51 | 1.526M |
| Sep 05, 2024 | 3.85 | 4.442 | 3.80 | 4.03 | 1.873M |
| Sep 04, 2024 | 4.39 | 4.44 | 3.96 | 3.96 | 1.109M |
| Sep 03, 2024 | 4.57 | 4.94 | 4.13 | 4.55 | 1.669M |
| Aug 30, 2024 | 5.23 | 5.52 | 4.63 | 4.66 | 2.166M |
| Aug 29, 2024 | 4.62 | 5.54 | 4.30 | 5.06 | 4.859M |
| Aug 28, 2024 | 6.25 | 7.63 | 4.80 | 4.87 | 67.73M |
| Aug 27, 2024 | 4.41 | 4.92 | 4.32 | 4.89 | 1.533M |
| Aug 26, 2024 | 5.22 | 5.29 | 4.200 | 4.61 | 4.125M |
| Aug 23, 2024 | 5.80 | 6.22 | 5.200 | 5.45 | 7.563M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.61
Minimum
May 02 2024
208.00
Maximum
Jul 28 2022
10.29
Average
3.70
Median
Aug 23 2023
Price Benchmarks
| Adaptimmune Therapeutics PLC | 0.9772 |
| Biodexa Pharmaceuticals PLC | 0.2876 |
| Verona Pharma PLC | 28.76 |
| NuCana PLC | 2.45 |
| Autolus Therapeutics PLC | 3.63 |
Price Related Metrics
| PS Ratio | 17.06 |
| PEG Ratio | -0.0001 |
| Price to Book Value | 1.570 |
| Earnings Yield | -921.9% |
| Market Cap | 8.424M |
| PEGY Ratio | -0.0001 |